Concanavalin A binding receptor sites in non-neoplastic and neoplastic transitional cell epithelium from tumour-bearing human urinary bladders were mapped ultrastructurally following successive incubation of vibratome slices with concanavalin A, peroxidase and diaminobenzidine. In the normal epithelium the reaction product was found in the plasma membranes of the basal cells. Some areas of the endoplasmatic reticulum and the discoid vesicles were reacting in all cell layers. In the neoplastic epithelium, reaction product was localized to the plasma membranes throughout the epithelium, irrespective of the grade of malignancy. The intracellular distribution was similar to that in normal epithelial cells. The topographical distribution suggests that concanavalin A binding glycoproteins are found in the transitional cell epithelium in immature membranes.

Keywords:
Concanavalin A binding receptor sites, Transmission electron microscopy, Transitional cell epithelium, Transitional cell carcinoma, Bladder carcinoma
This content is only available via PDF.
© 1980 S. Karger AG, Basel
1980
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.